1. Circulating N‐cadherin levels are a negative prognostic indicator in patients with multiple myeloma. (26th February 2013) Authors: Vandyke, Kate; Chow, Annie W.S.; Williams, Sharon A.; To, Luen B.; Zannettino, Andrew C.W. Journal: British journal of haematology Issue: Volume 161:Number 4(2013:May) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Therapeutic targeting of N‐cadherin is an effective treatment for multiple myeloma. (20th July 2015) Authors: Mrozik, Krzysztof M.; Cheong, Chee Man; Hewett, Duncan; Chow, Annie W.S.; Blaschuk, Orest W.; Zannettino, Andrew C.W.; Vandyke, Kate Journal: British journal of haematology Issue: Volume 171:Number 3(2015:Nov.) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗